Alcohol as a modifiable risk factor for Alzheimer's disease—Evidence from experimental studies

DV Chandrashekar, RA Steinberg, D Han… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
cognitive impairment and memory loss. Epidemiological evidence suggests that heavy …

[HTML][HTML] Multiple chemical sensitivity: it's time to catch up to the science

J Molot, M Sears, H Anisman - Neuroscience & Biobehavioral Reviews, 2023 - Elsevier
Multiple chemical sensitivity (MCS) is a complex medical condition associated with low dose
chemical exposures. MCS is characterized by diverse features and common comorbidities …

Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease

L Yang, Y Wang, G Zheng, Z Li, J Mei - International Journal of Biological …, 2023 - Elsevier
Resveratrol (Res) is a common natural polyphenol that inhibits inflammation and oxidative
stress in Alzheimer's disease (AD). However, the absorption efficiency and in vivo bioactivity …

Plasma caffeine levels and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomization study

SC Larsson, B Woolf, D Gill - Nutrients, 2022 - mdpi.com
We leveraged genetic variants associated with caffeine metabolism in the two-sample
Mendelian randomization framework to investigate the effect of plasma caffeine levels on the …

Autoimmune disease classification based on PubMed text mining

H Samuels, M Malov, T Saha Detroja… - Journal of Clinical …, 2022 - mdpi.com
Autoimmune diseases (AIDs) are often co-associated, and about 25% of patients with one
AID tend to develop other comorbid AIDs. Here, we employ the power of datamining to …

Helicobacter pylori and Alzheimer's Disease-Related Metabolic Dysfunction: Activation of TLR4/Myd88 Inflammation Pathway from p53 Perspective and a Case Study …

Z Ju, L Shen, M Zhou, J Luo, Z Yu, C Qu… - ACS Chemical …, 2022 - ACS Publications
Gut dysbiosis is observed in Alzheimer's disease (AD) and is frequently associated with AD-
induced metabolic dysfunction. However, the extent and specific underlying molecular …

Mitigation of memory impairment with fermented fucoidan and λ-carrageenan supplementation through modulating the gut microbiota and their metagenome function …

T Zhang, X Wu, H Yuan, S Huang, S Park - Cells, 2022 - mdpi.com
Attenuating acetylcholinesterase and insulin/insulin-like growth factor-1 signaling in the
hippocampus is associated with Alzheimer's disease (AD) development. Fucoidan and …

Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China

X Xiao, S Xiang, Q Xu, J Li, J Xiao, Y Si - Aging Clinical and Experimental …, 2023 - Springer
Objective To investigate comorbidities among hospitalized patients with dementia. Method
Data were extracted from the discharge records in our hospital. Comorbidities based on ICD …

Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy

J Hovanesian, IP Singh, A Bauskar… - Current Opinion in …, 2023 - journals.lww.com
Identifying and addressing common contributors to nonadheren... : Current Opinion in
Ophthalmology Identifying and addressing common contributors to nonadherence with …

Increased risk of osteoporosis in patients with cognitive impairment: a systematic review and meta-analysis

C Xie, C Wang, H Luo - BMC geriatrics, 2023 - Springer
Background Both osteoporosis and cognitive impairment affect overall health in elderly
individuals. This study aimed to investigate the association between cognitive impairment …